申请人:CircaGen Pharmaceutical, a Delaware corporation
公开号:US20020143037A1
公开(公告)日:2002-10-03
Histone deacetylase is a metallo-enzyme with zinc at the active site. Compounds having a zinc-binding moiety, such as, for example, a carboxylic acid group, can inhibit histone deacetylase. Histone deacetylase inhibition can repress gene expression, including expression of genes related to tumor suppression. Accordingly, inhibition of histone deacetylase can provide an alternate route for treating cancer, hematological disorders, e.g., hemoglobinopathies, and genetic related metabolic disorders, e.g., cystic fibrosis and adrenoleukodystrophy.
组蛋白去乙酰化酶是一种在活性位点含锌的金属酶。具有锌结合基团的化合物,例如,羧酸基团,可以抑制组蛋白去乙酰化酶。组蛋白去乙酰化酶的抑制可以抑制基因表达,包括与肿瘤抑制相关的基因的表达。因此,抑制组蛋白去乙酰化酶可以提供治疗癌症、血液学疾病(例如血红蛋白病)以及遗传相关代谢性疾病(例如囊性纤维化和肾上腺白质脑病)的另一途径。